Tenderwize
Back to tender search

Open Framework Agreement on Drug Discounts (2026-03)

Deutsche Rentenversicherung Knappschaft-Bahn-See·Bochum, Germany·Deadline Feb 05, 2028 · 538 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026­-03

0/100

Opportunity Score

High riskLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

0 / 100

Complexity

10 / 100

Risk factors

The notice explicitly cancels the procedure for all lots as of 30 June 2026. Participation is not possible.

No estimated contract value or award criteria (price/quality) are provided, making it impossible to assess commercial a...

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Weak opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration until Mar 2028
  • Supply of pharmaceutical product Etanercept in four dosage forms (ILO, PEN, IFE, PLI) under a framework agreement for discount contracts (Rabattverträge).
  • The tender is cancelled and no longer accepting participation.
Show full summary

This notice announces the cancellation of the open framework agreement for pharmaceutical discounts (Etanercept) under §130a Abs.8 SGB V, originally published on 11.12.2025 (notice 822904-2025). All four lots (ILO, PEN, IFE, PLI) are cancelled effective 30 June 2026. The tender is no longer open for participation.

Risks

The notice explicitly cancels the procedure for all lots as of 30 June 2026. Participation is not possible.

No estimated contract value or award criteria (price/quality) are provided, making it impossible to assess commercial a...

No procurement documents available

Key Requirements

Technical

  • Tender is cancelled as of 30 June 2026.
  • Original participation required pharmaceutical entrepreneur status per §4 Abs. 18 AMG.
  • Non-negotiable terms including fixed discount rate.

Requirements may be incomplete.

Buyer

Location

Bochum, DEU

Website

www.kbs.de

Identifier

992-80003-44

Activity

Health

Lots (4)

LOT-0001

Etanercept, injection (ILO)

Cancelled lot for Etanercept in ILO dosage form. Framework agreement with unlimited number of pharmaceutical entrepreneurs. Original period 01.04.2026–31.03.2028.

SuppliesFrameworkEU fundedElectronic submission

Location

DEA51, Germany

Duration

Mar 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0002

Etanercept, pen (PEN)

Cancelled lot for Etanercept in PEN dosage form. Framework agreement with unlimited number of pharmaceutical entrepreneurs. Original period 01.04.2026–31.03.2028.

SuppliesFrameworkEU fundedElectronic submission

Location

DEA51, Germany

Duration

Mar 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0003

Etanercept, injection (IFE)

Cancelled lot for Etanercept in IFE dosage form. Framework agreement with unlimited number of pharmaceutical entrepreneurs. Original period 01.04.2026–31.03.2028.

SuppliesFrameworkEU fundedElectronic submission

Location

DEA51, Germany

Duration

Mar 2026 - Mar 2028

Category

Pharmaceutical products

LOT-0004

Etanercept, Darreichungsform: PLI (ATC-Code: L04AB01)

Hiermit wird die Aufhebung des Verfahrens 2026-03 der ursprünglichen Veröffentlichung ( 822904-2025 vom 11.12.2025) zum 30.06.2026 bekanntgegeben.

SuppliesFrameworkEU fundedElectronic submission

Location

DEA51, Germany

Duration

Mar 2026 - Mar 2028

Category

Pharmaceutical products

Procurement Details

Publication date
25 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
354716-2026

Documents (1)

Similar tenders